Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role?
Clara Aguirre, Virginia Meca‐Lallana, Ana Barrios-Blandino, Beatriz del Río, José Vivancos
Topics & Concepts
NatalizumabMedicineMultiple sclerosisCoronavirus disease 2019 (COVID-19)Blockade2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyIntegrinVirologyInternal medicineReceptorDiseaseOutbreakInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchPeripheral Neuropathies and DisordersDermatological and COVID-19 studies